+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Smoking Cessation Market - Forecasts from 2019 to 2024

  • ID: 4835377
  • Report
  • September 2019
  • Region: Global
  • 100 pages
  • Knowledge Sourcing Intelligence LLP

FEATURED COMPANIES

  • Chrono Therapeutics Inc.
  • Cigna
  • Cipla Inc.
  • Ethismos Research Inc.
  • GSK Group of Companies
  • McNeil AB
  • MORE
The smoking cessation market is projected to grow at a CAGR of 14.86% to reach US$42.247 billion by 2024, from US$18.402 billion in 2018. Excessive intake of tobacco/nicotine can lead to tobacco or nicotine dependence causing severe health problems. Thus, quitting smoking helps in reducing the risks of developing smoking-related diseases. Treatment for tobacco or nicotine dependence requires repeated treatments which include medication and counselling. At present, the number of former smokers outweighs the current smokers. Hence, a high prevalence of smokers requires treatments related to smoking cessation, thus, fuelling the market growth in the forecast period. The United States from the North American region is expected to show a significant market share due to a high prevalence of smokers here. Furthermore, growing health awareness will provide an opportunity for the smoking cessation market to thrive during the forecast period and beyond.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the smoking cessation value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the smoking cessation market.

Major industry players profiled as part of the report are GSK group of companies, Dr. Reddy’s Laboratories Ltd., Cipla Inc., and Chrono Therapeutics Inc. among others.

Segmentation

The smoking cessation market has been analyzed through the following segments:

By Therapy

Nicotine Replacement Therapy
Non-Nicotine Replacement Therapy

By Product Type

Chewing Gum
Patches
Sprays and Inhalers
e-cigarettes
Others

By Geography

North America
USA
Canada
Mexico

South America
Brazil
Argentina
Others

Europe
Germany
France
United Kingdom
Spain
Others

Middle East and Africa
Saudi Arabia
Israel
Others

Asia Pacific
China
Japan
South Korea
India
Others
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Chrono Therapeutics Inc.
  • Cigna
  • Cipla Inc.
  • Ethismos Research Inc.
  • GSK Group of Companies
  • McNeil AB
  • MORE
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope Of The Study
1.4. Currency
1.5. Assumptions
1.6. Base, And Forecast Years Timeline

2. Research Methodology
2.1. Research Design
2.2. Secondary Sources

3. Executive Summary

4. Market Dynamics
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. Smoking Cessation Market By Therapy
5.1. Nicotine Replacement Therapy
5.2. Non-Nicotine Replacement Therapy

6. Smoking Cessation Market By Product Type
6.1. Chewing Gum
6.2. Patches
6.3. Sprays And Inhalers
6.4. Others

7. Smoking Cessation Market By Geography
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. United Kingdom
7.3.4. Spain
7.3.5. Others
7.4. Middle East And Africa
7.4.1. Saudi Arabia
7.4.2. Israel
7.4.3. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. South Korea
7.5.4. India
7.5.5. Others

8. Competitive Intelligence
8.1. Competitive Benchmarking and Analysis
8.2. Recent Investments And Deals
8.3. Strategies of Key Players

9. Company Profiles
9.1. GSK group of companies
9.2. Dr. Reddy's Laboratories Ltd.
9.3. Cipla Inc.
9.4. Cigna
9.5. Chrono Therapeutics Inc.
9.6. Pfizer Inc
9.7. Takeda Consumer Healthcare Company Limited.
9.8. Achieve Life Sciences, Inc.
9.9. McNeil AB
9.10. Ethismos Research Inc.
Note: Product cover images may vary from those shown
  • GSK Group of Companies
  • Dr. Reddy’s Laboratories Ltd.
  • Cipla Inc.
  • Cigna
  • Chrono Therapeutics Inc.
  • Pfizer Inc
  • Takeda Consumer Healthcare Company Limited.
  • Achieve Life Sciences, Inc.
  • McNeil AB
  • Ethismos Research Inc.
Note: Product cover images may vary from those shown
Adroll
adroll